Latest Breaking News On - மருந்து வைத்திருத்தல் நிறுவனம் - Page 6 : comparemela.com

Biohaven Announces Proposed Public Offering Of Common Shares News provided by Share this article Share this article NEW HAVEN, Conn., March 15, 2021 /PRNewswire/  Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a marketed drug for the acute treatment of migraine and a portfolio of innovative, late–stage product candidates targeting neurological diseases, including rare disorders, today announced that it has commenced an underwritten public offering of $200 million of its common shares.  All of the common shares to be sold in the offering will be offered by Biohaven.  In addition, Biohaven expects to grant the underwriter a 30-day option to purchase up to an additional $30 million of common shares at the public offering price, less underwriting discounts and commissions.  The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or th

New yorkUnited statesBiohaven pharmaceutical holding company ltdExchange commissionProspectus departmentGoldman sachs coBiohaven pharmaceutical holding companyGoldman sachsPharmaceutical holding companyபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுப்ரோஸ்பெக்டஸ் துறைகோல்ட்மேன் சாக்ஸ் இணைகோல்ட்மேன் சாக்ஸ்மருந்து வைத்திருத்தல் நிறுவனம்